Form 4: Tyra Biosciences Director Nina S. Kjellson Sells Shares

Director Nina S. Kjellson reports the sale of Tyra Biosciences (TYRA) common stock on February 5, 2025.

Summary

• On February 5, 2025, Nina S. Kjellson, a director of Tyra Biosciences, Inc. (TYRA), sold shares of common stock.
• She sold 1,890 shares indirectly through Canaan XI L.P. at a weighted average price of $13.7611.
• She also sold 3,511 shares indirectly through 2020+ Co-Investment L.P. Series 7 at the same weighted average price.
• Following these transactions, Kjellson indirectly owns 3,700,705 shares through Canaan XI L.P. and 443,885 shares through 2020+ Co-Investment L.P. Series 7.

Sentiment

Score: 5

Explanation: This is a neutral report of stock sales by a director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, although it is a common occurrence.

Key Dates